October 27, 2020
Article
New phase 1 data show the first-in-class oral therapy is not affected by the burden on metabolism via hepatic or renal disease.
October 04, 2020
October 01, 2020
This edition from the 10 Year Plan features perspective from leadership at WGO and Crohn's & Colitis Foundation, as well as survey results from gastroenterologists.
September 27, 2020
This article is the final installment of four articles exploring the epidemic of liver disease called nonalcoholic fatty liver disease and its more severe form, nonalcoholic steatohepatitis.
September 25, 2020
Podcast
Dr. Yuen discusses some new treatments in the pipeline and how personalized medicine could make an impact in HBV treatment.
September 20, 2020
This article is the third in a series of four articles exploring the epidemic of liver disease called nonalcoholic fatty liver disease and its more severe form, nonalcoholic steatohepatitis.
September 13, 2020
This article is the second in a series of four articles exploring the epidemic of liver disease called nonalcoholic fatty liver disease and its more severe form, nonalcoholic steatohepatitis.
September 06, 2020
This article is the first in a series of 4 articles exploring the epidemic of liver disease called nonalcoholic fatty liver disease and its more severe form, nonalcoholic steatohepatitis.
July 22, 2020
The association of DAA treatment with mortality did not differ by sex in the cirrhosis group.
June 26, 2020
Low-level viremia was transiently detectable in 21 recipients in the early post-transplant period, but not after 14 days.
